2016 New Study "Next Generation Sequencing Industry" :Market Analysis, Trend, Share, Growth, Size, Forcast 2022, Research
Description-
Executive
Summary
Next
Generation Sequencing
(NGS) technology has emerged as a higher throughput and much cheaper
alternative of sequencing DNA than traditional Sanger Sequencing. NGS
can be used primarily to identify genes responsible for inherited
skin disease, to detect mutations that play a role in diseases such
as cancer and to determine RNA expression level. The use of NGS
technology in clinical research and genome functions is constantly
increasing and there are many clinical diagnostic opportunities for
next generation sequencing such as in oncology screening, parental
screening, Alzheimer diseases, multiple sclerosis etc.
To
Browse a Report Detail with TOC @
http://www.researchmoz.us/global-next-generation-sequencing-market-trends-and-opportunities-2013-2018-report.html
The
growth of the overall NGS market is driven by continuous innovations
and developments in the market aimed at higher throughput, increased
accuracy, and affordable costs. However factors such as mismatch
between discovery and interpretation of samples, clinical translation
of genomic discoveries, difficulty in finding samples to sequence and
storage of sequence data hinders the growth of the market. In
addition, factors such as high reliability on grants and funding from
the government are still a challenge. The opportunities for the
growth of this market include developments in the pre-sequencing,
cloud computing, and NGS bioinformatics solutions. Next generation
sequencing technology is set to revolutionize applied markets like
diagnostics, drug discovery, biomarker discovery, personalized
medicine, agriculture and animals research in the near future.
Scope
of the Report
The
report titled “Global Next Generation Sequencing Market: Trends and
Opportunities (2013-2018)” analyzes the potential opportunities and
significant trends in the global Next Generation Sequencing market.
The report also provides detailed analysis of the global next
generation sequencing market, the Sanger Sequencing market and
provides specific focus on the clinical diagnostic opportunities of
the NGS technology. The report also profiles and analyzes the
business strategies of the leading companies operating in the
segment.
Company
Profiles
- Illumina
- Life Technology
- Roche
- Pacific Bioscience
Table
of Content
1.
Executive Summary
2.
Introduction
2.1
Genomic
2.1.1
Genome Analysis
2.2
Sanger Sequencing
2.2.1
Comparison between Sanger and Next Generation Sequencing
2.3
Next Generation Sequencing Methods
2.4
High Throughput Sequencing Technologies
2.5
Low Throughput Sequencing Technologies
3.
Global Market Size of Next Generation Sequencing Industry: Analysis
and Forecast
3.1
Global Market Size of Genomic Tool Industry
3.1.1
Market Share of Genomic Tools Industry by Segment
3.2
Global Market Size of Sequencing Industry
3.3
Global Market Size of Sanger Sequencing Industry
3.3.1
Reasons for Declining Sanger Sequencing Capacity Utilization
3.4
Global Market Size of Next Generation Sequencing Industry
3.5
Next Generation Sequencing Technology Users
3.6
Sequencing Cost per Genome
3.7
Most Limiting Aspects of Next Generation Sequencing Technologies to
Workflow
3.8
Funding Source of NGS Labs
4.
Clinical Diagnostic Opportunity for Next Generation Sequencing
4.1
NGS Based Test with Clinical Application
5.
Market Dynamics
5.1
Growth Drivers
5.1.1
Increasing Population
5.1.2
Global GDP
5.1.3
Increasing Count of Cancer Patients
5.2
Challenges
5.2.1
Discovery and Interpretation
5.2.2
Clinical Translation of Genomic Discoveries
5.2.3
Finding Samples to Sequence
5.2.4
Compute and Storage for Sequence Data
5.3
Market Trends
5.3.1
Cloud Computing
5.3.2
NGS Bioinformatics
5.3.3
Development in Pre-Sequencing
6.
Competitive Landscape
6.1
Comparison of High Throughput and Low Throughput Platforms by Company
6.2
Uses of Different Next Generation Systems
6.3
Revenue of the Companies in Next Generation Sequencing Market
6.4
Next Generation Sequencing Market Share by Company
6.5
Next Generation Sequencing Market Share in Clinical Research
Application by Company
6.6
Share of Company Products Used by NGS Labs
6.7
Revenue Share of Companies’ Instruments and Reagents
6.8
Comparison of Next Generation Technologies
6.9
Next Generation Sequencing Products Release Timeline by Product
Family
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Comments
Post a Comment